LYN InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain Caroline Smith 1 day ago ASX News Healthcare Medical Devices
RBL Recce scores $6.75M R&D rebate Recce Pharmaceuticals (ASX: RCE) has received a cash refund of $6,751,176 Research and Development (R&D) Tax Incentive rebate from the Australian Taxation Office for FY24. Sean Boss 2 days ago ASX 200 ASX News Healthcare
DLM Biome reaches intellectual property milestone in strain development program Biome Australia Ltd has achieved an important milestone in development of a biome strain, preparing for a transfer of intellectual property Caroline Smith 2 days ago ASX News Consumer Defensive Healthcare Household & Personal Products
AJQ Visionflex set to bank $1.75M to fund inventory expansion Visionflex Group Ltd has carried out an institutional Placement bringing in $1.75M, beyond its original target of $1.5M Caroline Smith 3 days ago Editorial Content Healthcare Medical Devices
ICG IDT Australia's buyout offer from Mynd scrapped as latter leaves IDT hanging IDT Australia (ASX:IDT) has confirmed its proposed takeover offer from a company called Myndbio for 15cps has been scrapped. Jonathon Davidson 3 days ago ASX News Healthcare
AS1 BlinkLab teams up with Monash to trial tech in autism, ADHD study BlinkLab (ASX:BB1) has confirimed its involvement in a Monash Uni-based study examining its tech's ability to diagnose autism and ADHD. Jonathon Davidson 3 days ago ASX News Healthcare Medical Devices
ACW Actinogen receives $9M R&D tax rebate to fund Alzheimer's trial Actinogen Medical Ltd has received a $9M R&D rebate from the Australian Taxation Office which will fund its activities through to mid-2026 Caroline Smith 4 days ago ASX News Healthcare Biotechnology
NHF Burgeoning NZ insurance claims drive 1H25 operating loss for nib nib Holdings Ltd is expecting an operating loss of $10M in the first half of the 2025 fiscal year due to a high volume of New Zealand claims Caroline Smith 4 days ago ASX News Financial Services Healthcare Insurance - Diversified
Neurizon's fast-track application for flagship drug in Europe received 'positively' Neurizon's (ASX:NUZ) hopes have been lifted with a view towards winning fast-track status from a European health regulator. Jonathon Davidson 5 days ago ASX News Healthcare
INA Imugene kicks off Australian trial for blood cancer treatment Imugene Ltd has opened its first Australian trial for a Phase 1b clinical trial to test CAR T cell therapy azer-cel Caroline Smith 08 Nov 2024 13:33 (AEDT) ASX News Healthcare Biotechnology
UBI Universal Biosensors flat despite fresh deal with US medical product distributor Universal Biosensors shares were flat on Friday, even as the microcap healthcare company inked a US distribution deal. Jonathon Davidson 08 Nov 2024 11:46 (AEDT) ASX News Healthcare Medical Devices
SIG ACCC greenlights Sigma Healthcare, Chemist Warehouse merger The Australian competition regulator has greenlit Sigma Healthcare's (ASX:SIG) plans to reverse list Chemist Warehouse. Jonathon Davidson 07 Nov 2024 09:49 (AEDT) ASX News Healthcare
Freedom Care Group reveals NDIS wants to ban it providing program services Shares in Freedom Care Group (ASX:FCG) were down more than -3% on Wednesday after revealing the NDIS wants to revoke its licence. Jonathon Davidson 06 Nov 2024 10:57 (AEDT) ASX News Healthcare
